One-Year Treatment Continuation in Patients Switched to Paliperidone Palmitate: A Retrospective Study

被引：4
|
作者：
Hamer, Jessica [1 ]
Norman, Trevor R. [1 ]
Kanaan, Richard A. A. [1 ]
机构：
[1] Univ Melbourne, Austin Hlth, Dept Psychiat, Melbourne, Vic, Australia
来源：
JOURNAL OF CLINICAL PSYCHIATRY | 2014年 / 75卷 / 11期
关键词：
SCHIZOPHRENIA; SAFETY; EFFICACY;
D O I：
10.4088/JCP.13l08866
中图分类号：
B849 [应用心理学];
学科分类号：
040203 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Retrospective one-year follow-up study of one-monthly paliperidone palmitate in in-patient unit
    Segura, E.
    Rodriguez, C.
    Asensio, L.
    Nuevo, L.
    Cabanillas, L.
    Gomez, I.
    Beato, L.
    EUROPEAN PSYCHIATRY, 2018, 48 : S194 - S195
  • [2] A one-year prospective study of the safety, tolerability and pharmacokinetics of the highest available dose of paliperidone palmitate in patients with schizophrenia
    Danielle Coppola
    Yanning Liu
    Srihari Gopal
    Bart Remmerie
    Mahesh N Samtani
    David W Hough
    Isaac Nuamah
    Ahmad Sulaiman
    Gahan Pandina
    BMC Psychiatry, 12
  • [3] A one-year prospective study of the safety, tolerability and pharmacokinetics of the highest available dose of paliperidone palmitate in patients with schizophrenia
    Coppola, Danielle
    Liu, Yanning
    Gopal, Srihari
    Remmerie, Bart
    Samtani, Mahesh N.
    Hough, David W.
    Nuamah, Isaac
    Sulaiman, Ahmad
    Pandina, Gahan
    BMC PSYCHIATRY, 2012, 12
  • [4] PALIPERIDONE PALMITATE: A ONE YEAR MIRROR IMAGE STUDY
    Hodgson, R.
    Atikum, R.
    Rajkumar, P.
    EUROPEAN PSYCHIATRY, 2014, 29
  • [5] From one-month to three-month paliperidone palmitate: an Italian real-world, retrospective, one-year mirror image study
    Cirnigliaro, G.
    Battini, V.
    Invernizzi, E.
    Mazhar, F.
    Vanzetto, S.
    Ferrara, L.
    Fasciana, F.
    Cafaro, R.
    Piccoli, E.
    Gobbo, D.
    Dell'Osso, B.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020, 40 : S263 - S264
  • [6] Long-term safety, tolerability and pharmacokinetics of paliperidone palmitate : A one-year open-label study in patients with schizophrenia
    Gopal, S.
    Coppola, D.
    Liu, Y.
    Remmerie, B.
    Samtani, M.
    Pandina, G.
    Hough, D.
    Nuamah, I.
    Sulaiman, A. H.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 219 - 219
  • [7] Paliperidone palmitate: factors predicting continuation with treatment at 2 years
    Taylor, David M.
    Sparshatt, Anna
    O'Hagan, Maria
    Dzahini, Olubanke
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 (12) : 2011 - 2017
  • [8] LONG-TERM SAFETY, TOLERABILITY AND PHARMACOKINETICS OF PALIPERIDONE PALMITATE: A ONE-YEAR OPEN-LABEL STUDY IN PATIENTS WITH SCHIZOPHRENIA.
    Coppola, D.
    Liu, Y.
    Gopal, S.
    Remmerie, B.
    Samtani, M.
    Pandina, G.
    Hough, D.
    Nuamah, I.
    Sulaiman, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S25 - S25
  • [9] Clinical relevance of Paliperidone Palmitate three-month intramuscular injection formulation: an Italian Real-World, Retrospective, one-year Mirror Image Study
    Vanzetto, S.
    Cirnigliaro, G.
    Battini, V.
    Piccoli, E.
    Vismara, M.
    Vigano, C.
    Dell'Osso, B.
    EUROPEAN PSYCHIATRY, 2022, 65 : S346 - S346
  • [10] Healthcare utilization and economics evaluation of paliperidone palmitate once-monthly in schizophrenia: a one-year, real-world, and retrospective mirror image study in China
    Zhou, Yixiang
    Chen, Binbin
    Huang, Yinghua
    FRONTIERS IN PSYCHIATRY, 2024, 15
12345